1. Home
  2. INAB vs CVR Comparison

INAB vs CVR Comparison

Compare INAB & CVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INAB
  • CVR
  • Stock Information
  • Founded
  • INAB 2016
  • CVR 1920
  • Country
  • INAB United States
  • CVR United States
  • Employees
  • INAB N/A
  • CVR N/A
  • Industry
  • INAB Biotechnology: Pharmaceutical Preparations
  • CVR Industrial Machinery/Components
  • Sector
  • INAB Health Care
  • CVR Industrials
  • Exchange
  • INAB Nasdaq
  • CVR Nasdaq
  • Market Cap
  • INAB 9.1M
  • CVR 9.8M
  • IPO Year
  • INAB 2021
  • CVR N/A
  • Fundamental
  • Price
  • INAB $2.00
  • CVR $10.10
  • Analyst Decision
  • INAB Strong Buy
  • CVR
  • Analyst Count
  • INAB 2
  • CVR 0
  • Target Price
  • INAB $108.00
  • CVR N/A
  • AVG Volume (30 Days)
  • INAB 45.9K
  • CVR 2.5K
  • Earning Date
  • INAB 11-11-2025
  • CVR 11-11-2025
  • Dividend Yield
  • INAB N/A
  • CVR 1.23%
  • EPS Growth
  • INAB N/A
  • CVR N/A
  • EPS
  • INAB N/A
  • CVR N/A
  • Revenue
  • INAB N/A
  • CVR $25,617,681.00
  • Revenue This Year
  • INAB N/A
  • CVR N/A
  • Revenue Next Year
  • INAB N/A
  • CVR N/A
  • P/E Ratio
  • INAB N/A
  • CVR N/A
  • Revenue Growth
  • INAB N/A
  • CVR N/A
  • 52 Week Low
  • INAB $1.91
  • CVR $8.15
  • 52 Week High
  • INAB $16.70
  • CVR $22.27
  • Technical
  • Relative Strength Index (RSI)
  • INAB 39.35
  • CVR 44.60
  • Support Level
  • INAB $1.91
  • CVR $9.01
  • Resistance Level
  • INAB $2.20
  • CVR $10.24
  • Average True Range (ATR)
  • INAB 0.11
  • CVR 0.34
  • MACD
  • INAB -0.01
  • CVR 0.10
  • Stochastic Oscillator
  • INAB 23.08
  • CVR 71.07

About INAB IN8bio Inc.

IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of gamma-delta T cell product candidates for solid and liquid tumors, by employing allogeneic, autologous, and genetically modified gamma-delta T cells. Its product candidates include INB-400, for the treatment of newly diagnosed glioblastoma, or GBM, INB-100 for the treatment of patients with high-risk leukemias undergoing hematopoietic stem cell transplantation, and other product candidates such as INB-200, INB-300, and INB-500.

About CVR Chicago Rivet & Machine Co.

Chicago Rivet & Machine Co is in the fastener industry in North America. The company operates in two segments namely fasteners and assembly equipment. Its fastener segment consists of the manufacture and sale of rivets, cold-formed fasteners, parts, and screw machine products. The assembly equipment segment consists mainly of the manufacture of automatic rivet setting machines, automatic assembly equipment, and parts and tools for such machines. The majority of revenue is from the fastener segment.

Share on Social Networks: